Present status of quinoxaline motifs: Excellent pathfinders in therapeutic medicine

OO Ajani - European journal of medicinal chemistry, 2014 - Elsevier
Quinoxalines belong to a class of excellent heterocyclic scaffolds owing to their wide
biological properties and diverse therapeutic applications in medicinal research. They are …

New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies

MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah… - RSC …, 2021 - pubs.rsc.org
A new series of 3-methylquinoxaline-based derivatives having the same essential
pharmacophoric features as VEGFR-2 inhibitors have been synthesized and evaluated for …

Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR …

C Ma, MS Taghour, A Belal, ABM Mehany… - Frontiers in …, 2021 - frontiersin.org
Guided by the structural optimization principle and the promising anticancer effect of the
quinoxaline nucleus, a new series of novel HDAC inhibitors were designed and …

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers

MM Alanazi, IH Eissa, NA Alsaif… - Journal of Enzyme …, 2021 - Taylor & Francis
Vascular endothelial growth factor receptor-2 (VEGFR-2) plays a critical role in cancer
angiogenesis. Inhibition of VEGFR-2 activity proved effective suppression of tumour …

Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis …

HA Mahdy, MK Ibrahim, AM Metwaly, A Belal… - Bioorganic …, 2020 - Elsevier
Inhibiting VEGFR-2 has been set up as a therapeutic strategy for treatment of cancer.
Accordingly, new quinazoline-based derivatives having the structural features of VEGFR-2 …

Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors

MS Alesawy, AA Al‐Karmalawy… - Archiv Der …, 2021 - Wiley Online Library
Abstract A new series of 1, 2, 4‐triazolo [4, 3‐c] quinazoline derivatives was designed and
synthesized as Topo II inhibitors and DNA intercalators. The cytotoxic effect of the new …

Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers

AA Gaber, AH Bayoumi, AM El-Morsy, FF Sherbiny… - Bioorganic …, 2018 - Elsevier
In our attempt to develop effective EGFR-TKIs, two series of 1H-pyrazolo [3, 4-d] pyrimidine
derivatives were designed and synthesized. All the newly synthesized compounds were …

Overview of chemistry and therapeutic potential of non-nitrogen heterocyclics as anticonvulsant agents

R Pal, K Singh, J Paul, SA Khan… - Current …, 2022 - benthamdirect.com
Epilepsy is a chronic neurological disorder, characterized by the predisposition of
unprovoked seizures affecting the neurobiological, psychological, cognitive, economic, and …

Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers

EM Abbass, AK Khalil, MM Mohamed, IH Eissa… - Bioorganic …, 2020 - Elsevier
As an extension for our earlier effort in the field of discovery of anticancer agents acting on
DNA and Topo II, eighteen quinoxaline derivatives were designed and synthesized. Such …

Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study

MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah… - Journal of Molecular …, 2022 - Elsevier
VEGFR-2 is one of the most vital targets for the treatment of solid tumors. This work
represents synthetic approaches of new set of quinoxaline-based derivatives having …